Research shows it plays a crucial role in wound healing, tissue remodeling, and skin regeneration
A randomized, double-blind, controlled phase II trial in advanced renal cell carcinoma (RCC) demonstrated synergistic anticancer effects with the combination of the glutaminase inhibitor telaglenastat (CB-839) and the mTOR inhibitor everolimus (TelaE), which was well tolerated by patients previously treated with TKIs
As the landscape of longevity medicine shifts in 2026, many individuals are moving away from unregulated research chemicals toward medically supervised peptide protocols designed to optimize sleep, body composition, and recovery
Urine samples have their unique challenges: the privacy of collection, the taboo with urine, the need for samples have to be spaced 2-4 hours apart for more precise assessment, the careful control of volume remaining in the bladder and the mixing from remaining volume in the bladder from last urination of the by product (6-sulphatoxymelatonin)
Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas
